Liraglutide shows efficacy in boosting liver enzymes in diabetes

12/2/2012 | Modern Medicine

Data from six Liraglutide Effect and Action in Diabetes program trials showed liraglutide and other GLP-1 analogues were safe and effective in improving liver enzymes in overweight type 2 diabetes patients. Liraglutide also fared better than placebo in reducing alanine transaminase levels in patients, researchers wrote in the journal Alimentary Pharmacology and Therapeutics.

View Full Article in:

Modern Medicine

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA